Assessing the effect of patient and prescriber preference in trials of treatment of depression in general practice
Andrew ThornettMed Sci Monit 2001; 7(5): RA1086-1091 :: ID: 509356
Abstract
Preferences include the choices made by individuals when presented with options for treatment for depression, and the system of beliefs and views that underlies those choices. They are informed by the experience of previous treatment by individuals, their family and friends, information from medical professionals and the media, and incorporates biases and ideologies present within the population. Although the randomised controlled trial is generally considered to be the optimal method for evaluating the effectiveness of health care interventions, [1] patients may become less motivated to follow the treatment protocol if they are not allocated to their preferred treatment. Consequently, the relevant arms of the study may appear less effective as a result. Further, following an invitation to join a clinical trial, patients may refuse randomisation and be excluded from the trial if they have strong treatment preferences, leading to the introduction of bias and restricted ability to generalise the results, as participants may not be representative. Considerable demand has been shown by patients for psychological treatments for the treatment of depression in primary care. However, two recent studies have not demonstrated a relationship between being allowed to choose treatment and short-term depression outcome. These two studies explored primary care patients treated with antidepressants or counselling, and non-directive counselling, cognitive-behaviour therapy or usual general practitioner care. Further work is needed to determine the effects of preferences within different study designs and to explore the views of both professionals and patients using appropriate qualitative designs.
Keywords: preference, primary care, Depression
Editorial
01 April 2024 : Editorial
Editorial: Forty Years of Waiting for Prevention and Cure of HIV Infection – Ongoing Challenges and Hopes for Vaccine Development and Overcoming Antiretroviral Drug ResistanceDOI: 10.12659/MSM.944600
Med Sci Monit 2024; 30:e944600
In Press
21 Mar 2024 : Meta-Analysis
Economic Evaluation of COVID-19 Screening Tests and Surveillance Strategies in Low-Income, Middle-Income, a...Med Sci Monit In Press; DOI: 10.12659/MSM.943863
10 Apr 2024 : Clinical Research
Predicting Acute Cardiovascular Complications in COVID-19: Insights from a Specialized Cardiac Referral Dep...Med Sci Monit In Press; DOI: 10.12659/MSM.942612
06 Mar 2024 : Clinical Research
Enhanced Surgical Outcomes of Popliteal Cyst Excision: A Retrospective Study Comparing Arthroscopic Debride...Med Sci Monit In Press; DOI: 10.12659/MSM.941102
06 Mar 2024 : Clinical Research
Prevalence and Variation of Medical Comorbidities in Oral Surgery Patients: A Retrospective Study at Jazan ...Med Sci Monit In Press; DOI: 10.12659/MSM.943884
Most Viewed Current Articles
17 Jan 2024 : Review article
Vaccination Guidelines for Pregnant Women: Addressing COVID-19 and the Omicron VariantDOI :10.12659/MSM.942799
Med Sci Monit 2024; 30:e942799
14 Dec 2022 : Clinical Research
Prevalence and Variability of Allergen-Specific Immunoglobulin E in Patients with Elevated Tryptase LevelsDOI :10.12659/MSM.937990
Med Sci Monit 2022; 28:e937990
16 May 2023 : Clinical Research
Electrophysiological Testing for an Auditory Processing Disorder and Reading Performance in 54 School Stude...DOI :10.12659/MSM.940387
Med Sci Monit 2023; 29:e940387
01 Jan 2022 : Editorial
Editorial: Current Status of Oral Antiviral Drug Treatments for SARS-CoV-2 Infection in Non-Hospitalized Pa...DOI :10.12659/MSM.935952
Med Sci Monit 2022; 28:e935952